ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,481Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1128

$2.84M Total Retail Price of All Prescriptions

Rank: 3 out of 1128

1,366 Patients Receiving at Least One Drug in Part D
51% Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 1,366 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 1,366 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$111 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,762 714 316 S3 1 6
OMEPRAZOLE 1,220 675 261 2 5
LISINOPRIL 769 490 128 3 4
CLOPIDOGREL 703 361 151 4 18
FUROSEMIDE 647 414 99 5 7
SIMVASTATIN 632 410 131 6 2
ALPRAZOLAM 452 228 81 B 7 12
CLONAZEPAM 442 172 100 B 8 51
METFORMIN HCL 439 307 80 9 9
NEXIUM 435 202 72 10 28
LEVOTHYROXINE SODIUM 394 229 59 11 1
METOPROLOL TARTRATE 339 221 63 12 10
RANITIDINE HCL 335 141 77 13 37
FLUOXETINE HCL 294 162 59 14 59
POTASSIUM CHLORIDE 292 180 62 15 15
GABAPENTIN 272 147 65 16 11
PANTOPRAZOLE SODIUM 257 193 40 17 25
PENTOXIFYLLINE 244 109 63 18 283
ATORVASTATIN CALCIUM 241 199 32 19 8
AMLODIPINE BESYLATE 238 188 44 20 3
LORAZEPAM 230 130 50 B 21 27
SERTRALINE HCL 223 190 23 22 22
ZOLPIDEM TARTRATE 217 71 50 23 24
TRAMADOL HCL 214 139 57 24 29
GLYBURIDE 214 152 35 R 24 84
CYCLOBENZAPRINE HCL 203 68 51 R 26 94
BENAZEPRIL HCL 195 129 31 27 46
MELOXICAM 182 107 35 28 23
RAMIPRIL 182 146 17 28 78
AMITRIPTYLINE HCL 181 97 37 R 30 69
TAMSULOSIN HCL 180 165 27 31 30
PROAIR HFA 177 72 69 32 40
HYDROCHLOROTHIAZIDE 169 90 27 33 14
WARFARIN SODIUM 167 114 37 34 17
CARVEDILOL 166 115 38 35 21
PROMETHAZINE HCL 164 34 64 R 36 79
GLIMEPIRIDE 157 133 33 37 32
NAMENDA 154 135 12 38 44
WELCHOL 148 65 68 39 195
ALLOPURINOL 146 79 20 40 31
NAPROXEN 145 84 35 41 124
CITALOPRAM HBR 143 100 18 42 20
SUCRALFATE 139 74 61 43 173
DONEPEZIL HCL 139 <11 <11 43 35
OLANZAPINE 138 117 11 A 45 150
CARISOPRODOL 136 14 25 R 46 97
CEPHALEXIN 132 78 78 47 116
PHENYTOIN SODIUM EXTENDED 128 60 14 48 144
METHYLPREDNISOLONE 128 80 97 48 90
CYMBALTA 122 46 21 50 47
PROPRANOLOL HCL 119 17 18 51 114
SYMBICORT 117 50 39 52 139
MONTELUKAST SODIUM 113 45 28 53 43
TRAZODONE HCL 113 46 24 53 39
LYRICA 111 46 20 55 80
LANTUS 110 77 20 56 64
CIPROFLOXACIN HCL 108 81 73 57 63
DOXEPIN HCL 105 18 19 58 201
PRAVASTATIN SODIUM 105 66 24 58 13
AZITHROMYCIN 104 61 70 60 54
BD ULTRA-FINE PEN NEEDLE 103 64 32 61 129
FAMOTIDINE* 98 <11 <11 62 66
PEG 3350-ELECTROLYTE 97 45 94 63 371
LOVASTATIN 97 31 21 63 36
SPIRONOLACTONE 96 54 15 65 58
QUETIAPINE FUMARATE 95 67 15 A 66 60
DEXILANT 94 27 26 67 122
TIZANIDINE HCL 92 53 22 68 103
DIAZEPAM 90 29 33 B 69 72
TRILIPIX 90 20 20 69 280
PEGASYS PROCLICK 90 <11 17 10 69 417
METOPROLOL SUCCINATE 88 <11 <11 72 26
DICLOFENAC SODIUM 88 51 25 72 123
GEMFIBROZIL 88 52 21 72 95
HYDROXYZINE HCL 87 31 17 R 75 179
FORTEO 83 42 16 76 385
SPIRIVA 80 57 22 77 56
DIOVAN 80 50 18 77 52
DILTIAZEM 24HR ER 78 45 15 79 130
NOVOLOG 77 45 18 80 151
METOCLOPRAMIDE HCL 77 27 29 80 131
METHOCARBAMOL 76 14 14 R 82 185
POLYETHYLENE GLYCOL 3350 76 31 20 82 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 40 23 82 38
LOSARTAN POTASSIUM 76 57 19 82 16
FLUTICASONE PROPIONATE 73 32 31 86 33
ESCITALOPRAM OXALATE 71 <11 <11 87 53
MIRTAZAPINE 71 <11 <11 87 55
AMOXICILLIN 70 36 54 89 136
CARBIDOPA-LEVODOPA 70 <11 <11 89 125
EXELON 70 55 14 89 121
OXYBUTYNIN CHLORIDE 69 <11 <11 92 119
VYTORIN 67 <11 <11 93 204
KLOR-CON M20 66 44 19 94 89
EXFORGE 66 <11 <11 94 193
PREDNISONE 65 36 25 96 48
ACETAMINOPHEN-CODEINE 63 29 33 S3 97 167
ZETIA 62 27 15 98 77
THEOPHYLLINE ANHYDROUS 61 56* 14 99 181
CLONIDINE HCL 59 28 13 100 42
ROPINIROLE HCL 59 41 13 100 85
ADVAIR DISKUS 58 24 14 102 67
DILTIAZEM 24HR CD 58 41 11 102 134
DIVALPROEX SODIUM 58 38 11 102 88
HUMALOG 58 35 12 102 135
AMIODARONE HCL 58 <11 <11 102 169
FENTANYL 57 <11 <11 S2 107 112
RIBAVIRIN 56 <11 11 10 108 478
AMOX TR-POTASSIUM CLAVULANATE 56 29 40 108 101
LANTUS SOLOSTAR 56 30 14 108 98
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 38 31 111 106
PAROXETINE HCL 54 11 11 112 61
FENOFIBRATE* 53 <11 <11 113 71
ISOSORBIDE DINITRATE 53 <11 <11 113 219
TRIFLUOPERAZINE HCL 52 <11 <11 A 115 491
HALOPERIDOL 52 <11 <11 A 115 239
RANEXA 50 18 18 117 247
OXYCODONE-ACETAMINOPHEN 50 29 28 S2 117 110
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.